Myelodysplastic Syndromes

Showing NaN - NaN of 66

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphoma, Myeloma Trial in Miami, Chicago, San Antonio (LLS Program)

Not yet recruiting
  • Leukemia
  • +4 more
  • LLS Program
  • Miami, Florida
  • +2 more
Feb 16, 2023

MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Tamibarotene + Azacitidine
  • Tamibarotene Matched Placebo + Azacitidine
  • Tucson, Arizona
  • +87 more
Feb 2, 2023

Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

Withdrawn
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
Jan 31, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

Terminated
  • Hematopoietic Stem Cell Transplantation
  • +4 more
  • Duarte, California
  • +3 more
Oct 18, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)

Active, not recruiting
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +65 more
Aug 19, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +23 more
Aug 1, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +94 more
Jun 9, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

Completed
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia (AML)
  • Chicago, Illinois
  • +5 more
Mar 15, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Marina Del Rey, California
  • +35 more
Mar 11, 2022

Acute Myeloid Leukemia, MDS Trial in United States (CG-806)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +9 more
Mar 4, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, MDS Trial in United States (CliniMacs TCR alpha-beta-Biotin system)

Enrolling by invitation
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CliniMacs TCR alpha-beta-Biotin system
  • Los Angeles, California
  • +9 more
Feb 10, 2022

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • TregGraft (Orca-T)
  • Duarte, California
  • +13 more
Oct 28, 2021

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Duarte, California
  • +95 more
Sep 1, 2021

Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

Active, not recruiting
  • Hematopoietic Stem Cell Transplantation
  • +4 more
  • Duarte, California
  • +3 more
Jul 19, 2021

Classical Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in Chicago (Pembrolizumab)

Recruiting
  • Classical Hodgkin Lymphoma
  • +3 more
  • Chicago, Illinois
    University of Chicago
Jun 29, 2021

MDS Trial in France, Germany, United States (Oral rigosertib)

Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
Jun 15, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    MDS Trial in Canada, United States (anti-thymocyte globulin)

    Completed
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • Washington, District of Columbia
    • +27 more
    Jan 24, 2021